-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AAyk3uAGQavV93NLI0Mw0Vqz95DM4en9X+W7PSMVl/H8ba8NWIdsZgKNVxSS+ptX wRIQPgpwiFqo8GGoZAw+Dg== 0000929638-03-000032.txt : 20030214 0000929638-03-000032.hdr.sgml : 20030214 20030214142859 ACCESSION NUMBER: 0000929638-03-000032 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CONCEPTUS INC CENTRAL INDEX KEY: 0000896778 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 973170244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-49585 FILM NUMBER: 03566311 BUSINESS ADDRESS: STREET 1: 1021 HOWARD AVE CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 4158027240 MAIL ADDRESS: STREET 1: 1021 HOWARD AVENUE CITY: SAN CARLOS STATE: CA ZIP: 94070 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TARGET THERAPEUTICS INC CENTRAL INDEX KEY: 0000882238 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 953962471 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 47201 LAKEWIEW BLVD CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 5104407700 MAIL ADDRESS: STREET 1: 47201 LAKEVIEW BLVD CITY: FREMONT STATE: CA ZIP: 94538 SC 13G/A 1 a1192230.txt AMENDMENT NO. 2 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13D-102) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2)1 CONCEPTUS, INC. ----------------------------------------------------------------- (Name of Issuer) Common Stock, $0.003 par value per share ------------------------------------------------------ (Title or Class of Securities) 206016107 -------------------------------------------------------------------------- (CUSIP Number) December 31, 2002 --------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - -------- 1/ The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - --------- --------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Target Therapeutics, Inc. - --------- --------------------------------------------------------------------- - --------- --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [] N/A (B) [] - --------- --------------------------------------------------------------------- 3 SEC USE ONLY - --------- --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION The State of Delaware - --------- --------------------------------------------------------------------- - -------------------------------- ---------- ----------------------------------- 5 SOLE VOTING POWER 0 ---------- ----------------------------------- NUMBER OF ---------- ----------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 0 EACH ---------- ----------------------------------- REPORTING ---------- ----------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 0 ---------- ----------------------------------- ---------- ----------------------------------- 8 SHARED DISPOSITIVE POWER 0 - -------------------------------- ---------- ----------------------------------- - --------- --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - --------- --------------------------------------------------------------------- - --------- --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A [] - --------- --------------------------------------------------------------------- - --------- --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0 - --------- --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO - --------- --------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! ITEM 1(A). NAME OF ISSUER: Conceptus, Inc. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 1021 Howard Avenue San Carlos, CA 94070 ITEM 2(A). NAME OF PERSON FILING: Target Therapeutics, Inc. ITEM 2(B). ADDRESS OF PRINICIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 47900 Bayside Parkway Fremont, CA 94538 ITEM 2(C). CITIZENSHIP: The State of Delaware ITEM 2(D). TITLE OF CLASS OF SECURITIES: Common Stock, $0.003 par value per share (the "shares") ITEM 2(E). CUSIP NUMBER: 206016107 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR 13D-2(B), CHECK WHETHER THE PERSON FILING IS A: Not applicable. ITEM 4. OWNERSHIP: (a) Amount beneficially owned: 0 (b) Percent of class: 0 (c) Number of shares as to which such person has: (i) Sole Power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: [X] ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not applicable. ITEM 10. CERTIFICATIONS: Not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 13, 2003 ------------------ (Date) TARGET THERAPEUTICS, INC. By: /s/ Lawrence J. Knopf ------------------------------------ Name: Lawrence J. Knopf Title: Assistant Secretary -----END PRIVACY-ENHANCED MESSAGE-----